[ Price : $8.95]
An online report faults FDA for taking more than 30 years to approve new sunscreen regulations.[ Price : $8.95]
Teva Pharmaceuticals and Onco Genex Pharmaceuticals initiate a Phase 3 trial SYNERGY to evaluate custirsen as as first line therap...[ Price : $8.95]
Novartis Pharmaceuticals agrees to pay $423 million in criminal and civil fines to resolve a U.S. Attorney's Office (Eastern Distr...[ Price : $8.95]
The American Clinical Laboratory Association and the Genetic Alliance urge FDA to use notice and comment rulemaking to develop a r...[ Price : $8.95]
CDRH 510(k) staff director Heather Rosecrans retires from the agency and joins other former FDAers at regulatory consulting firm G...[ Price : $8.95]
Federal Register Final rule: FDA amends its regulations on safety reporting requirements for drugs and biologics subject to an inv...[ Price : $8.95]
Federal Register Notice: FDA releases a draft guidance on safety reporting requirements for investigational new drugs and bioavail...